Molecular Care Labs Profile
Key Indicators
- Authorised Capital ₹ 7.50 M
as on 15-11-2024
- Paid Up Capital ₹ 0.10 M
as on 15-11-2024
- Company Age 12 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.29 Cr
as on 15-11-2024
- Revenue -46.24%
(FY 2023)
- Profit -77.93%
(FY 2023)
- Ebitda -68.36%
(FY 2023)
- Net Worth 16.60%
(FY 2023)
- Total Assets -5.80%
(FY 2023)
About Molecular Care Labs
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 7.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹4.29 Cr.
Vasudevan Kumar and Kuttappan Sangeetha serve as directors at the Company.
- CIN/LLPIN
U85100KA2012PTC062334
- Company No.
062334
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Feb 2012
- Date of AGM
28 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Mysore, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Molecular Care Labs?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vasudevan Kumar  | Director | 01-Feb-2012 | Current |
| Kuttappan Sangeetha | Director | 20-Feb-2014 | Current |
Financial Performance of Molecular Care Labs.
Molecular Care Labs Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 46.24% decrease. The company also saw a substantial fall in profitability, with a 77.93% decrease in profit. The company's net worth Soared by an impressive increase of 16.6%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Molecular Care Labs?
In 2023, Molecular Care Labs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 14 May 2024 | ₹2.45 Cr | Open |
Tata Capital Housing Finance Limited Creation Date: 31 May 2023 | ₹9.00 M | Open |
Hdfc Bank Limited Creation Date: 21 Apr 2023 | ₹3.90 M | Open |
How Many Employees Work at Molecular Care Labs?
Molecular Care Labs has a workforce of 3 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Molecular Care Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Molecular Care Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
